General Information
Version
1.0
Revision date
2018-12-18
Product name
Novolin R, Actrapid
CAS No.
11061-68-0
1.2.1 Relevant identified uses
Pharmaceutical drug, use acording to package insert
1.2.2. Uses advised against
- The full text of any mentioned and identified use categories are given in section 16
Icons in SDS
Company Information
company name
Novo Nordisk A/S
e-mail address of the competent person responsible for the Safety Data Sheet
SDSsupport@novonordisk.com
GHS Information
Signal word
-
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Hazard pictograms
Not applicable
Signal word
-
Hazard statements
Not applicable
Precautionary statements
General -
Prevention
-
Response
-
Storage
-
Disposal
- Identity of the substances primarily responsible for the major health hazards Not applicable
2.3 Other hazards
The substance is a pharmacologically active substance. If the substance is absorbed systemically by inhalation, it has blood-sugar lowering properties. An overdose of inhaled substance may lead to a state of hypoglycaemia, especially in diabetic individuals. Hypoglycaemia is in severe cases lethal if untreated.
Additional information
Not applicable Additional warnings Not applicable VOC (volatile organic compound) Not applicable
2.1 Classification of the substance or mixture
Not classified according to Regulation (EC) No. 1272/2008 (CLP)
